Matt Gline, Roivant Sciences CEO (Photo by John Sciulli/Getty Images for GLG)

Pfiz­er and Roivant team up again for an­oth­er 'Van­t', set­ting up an­ti-in­flam­ma­to­ry show­down with Prometheus

Pfiz­er and Roivant are team­ing up to launch a new ‘Vant’ aimed at bring­ing a mid-stage an­ti-in­flam­ma­to­ry drug to mar­ket, the pair an­nounced Thurs­day. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.